Strategic Early Material Generation For Accelerated Process Development

Rapid access to early-stage material has become increasingly important for developability assessment and process development in biologics, particularly as growing molecular complexity continues to extend development timelines through additional optimization and troubleshooting requirements.

In this on-demand webinar, Samsung Biologics presented its approach to early material generation, designed to support both speed and scalability from the earliest stages of development. By aligning material generation with cell line development (CLD), incorporating early optimization activities such as media and process condition screening, and leveraging integration strategies within a stable expression platform, the company demonstrated how it can consistently supply high-quality, production-relevant material while minimizing variability across development stages.

The webinar also highlighted how this streamlined workflow enables the production of material nearly equivalent to that derived from a single-clone source, helping reduce development time and process complexity while improving overall resource efficiency. Through case studies showcasing scalable material production from flask to bioreactor, the session illustrated how early-stage decisions can accelerate the transition from sequence to material, support early developability assessments, and enable downstream applications requiring larger quantities of material, including formulation studies and other material-intensive activities.